GA HB1275

Permits physicians, physician assistants, and nurse practitioners to perform human stem cell therapies not yet approved by the FDA, provided treatments fall within their scope of practice and patients sign consent forms

Prohibits the use of human stem cells derived from aborted fetuses or embryos in stem cell therapies, while encouraging alternative sources such as adult stem cells and umbilical cord Wharton's jelly mesenchymal stem cells

Requires stem cells to be obtained only from facilities registered with the FDA or certified by approved organizations including the National Marrow Donor Program, American Association of Tissue Banks, or World Marrow Donor Association

Mandates that advertisements for non-FDA-approved stem cell therapies include a prominent notice informing patients the treatment lacks FDA approval and recommending consultation with a primary care provider

Subjects physicians or their designees who violate these requirements to disciplinary action by their respective professional licensing boards